Chargement en cours...

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer for which there is no effective treatment. Previously, we and others demonstrated that CXCR4 surface expression is an independent prognostic factor for disease relapse and survival in breast cancer. In this study, we investi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Liang, Sixian, Peng, Xun, Li, Xiaoli, Yang, Ping, Xie, Linhao, Li, Yaochen, Du, Caiwen, Zhang, Guojun
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359214/
https://ncbi.nlm.nih.gov/pubmed/25544759
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!